{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:07:28Z","timestamp":1756426048981,"version":"3.44.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SHK, s.r.o.","award":["311070AKF2"],"award-info":[{"award-number":["311070AKF2"]}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.xphs.2025.103843","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T19:24:48Z","timestamp":1748892288000},"page":"103843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Disintegration-dissolution modeling of bilayer tablets: Predicting plasma profiles and antimicrobial efficacy under postprandial conditions"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1300-4073","authenticated-orcid":false,"given":"Stefan","family":"Horkovics-Kovats","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jozef","family":"Federi\u010d","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Kinzig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fritz","family":"S\u00f6rgel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.xphs.2025.103843_bib0001","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a025247","article-title":"\u03b2-lactams and \u03b2-lactamase inhibitors: an overview","volume":"6","author":"Bush","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"3","key":"10.1016\/j.xphs.2025.103843_bib0002","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/clpt.1994.138","article-title":"Differential absorption of amoxicillin from the human small and large intestine","volume":"56","author":"Barr","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.xphs.2025.103843_bib0003","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/39.1.5","article-title":"The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infection","author":"Erah","year":"1997","journal-title":"J Antimicrob Chemother"},{"year":"2002","author":"Almeida","series-title":"Kinetic Studies on Clavulanic Acid Degradation","key":"10.1016\/j.xphs.2025.103843_bib0004"},{"issue":"1","key":"10.1016\/j.xphs.2025.103843_bib0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bej.2004.10.007","article-title":"Kinetic studies on clavulanic acid degradation","volume":"23","author":"Bersanetti","year":"2005","journal-title":"Biochem Eng J"},{"year":"2002","series-title":"Guidance for Industry Food-Effect Bioavailability and Fed Bioequivalence Studies","key":"10.1016\/j.xphs.2025.103843_bib0006"},{"issue":"Suppl ad","key":"10.1016\/j.xphs.2025.103843_bib0007","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000202161","article-title":"Quantitative Blutspiegeluntersuchungen \u00fcber die Kinetik der D\u00fcnndarmresorption","volume":"104","author":"K\u00fcbler","year":"1965","journal-title":"Gastroenterologia"},{"issue":"2","key":"10.1016\/j.xphs.2025.103843_bib0008","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ejpb.2008.05.011","article-title":"Bioavailability of amoxicillin and clavulanic acid from extended release tablets depends on intragastric tablet deposition and gastric emptying","volume":"70","author":"Weitschies","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"10.1016\/j.xphs.2025.103843_bib0009","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0891-5520(03)00065-5","article-title":"Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid","volume":"17","author":"Craig","year":"2003","journal-title":"Infect Dis Clin N Am"},{"year":"1998","author":"Craig","series-title":"Pharmacokinetic\/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and Men Downloaded From","key":"10.1016\/j.xphs.2025.103843_bib0010"},{"issue":"4","key":"10.1016\/j.xphs.2025.103843_bib0011","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrmicro862","article-title":"Antimicrobial pharmacodynamics: Critical interactions of \u201cbug and drug\u201d","volume":"2","author":"Drusano","year":"2004","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"10.1016\/j.xphs.2025.103843_bib0012","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bej.2009.02.013","article-title":"Stability of clavulanic acid under variable pH, ionic strength and temperature conditions. A new kinetic approach","volume":"45","author":"Santos","year":"2009","journal-title":"Biochem Eng J"},{"key":"10.1016\/j.xphs.2025.103843_bib0013","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/jps.23767","article-title":"Disintegration rate and properties of active pharmaceutical ingredient particles as determined from the dissolution time profile of a pharmaceutical formulation: an inverse problem","volume":"103","author":"Horkovics-Kovats","year":"2014","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.103843_bib0014","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ejps.2015.07.017","article-title":"Population data analysis of dissolution time profiles: Assessment of physicochemical properties of the drug, drug particles and the pharmaceutical formulation","volume":"78","author":"Horkovics-Kovats","year":"2015","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2025.103843_bib0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0939-6411(01)00178-3","article-title":"Determination of the disintegration behavior of magnetically marked tablets","volume":"52","author":"Weitschies","year":"2001","journal-title":"Eur J Pharm Biopharm"},{"issue":"6","key":"10.1016\/j.xphs.2025.103843_bib0016","first-page":"64","article-title":"Mathematical comparison of dissolution profiles","volume":"20","author":"Moore","year":"1996","journal-title":"Pharm Technol"},{"issue":"1","key":"10.1016\/j.xphs.2025.103843_bib0017","doi-asserted-by":"crossref","first-page":"E60","DOI":"10.1208\/aapsj0901007","article-title":"A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples","volume":"9","author":"Bauer","year":"2007","journal-title":"AAPS J"},{"issue":"2","key":"10.1016\/j.xphs.2025.103843_bib0018","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1208\/s12248-011-9257-x","article-title":"Development of a new pre- and post-processing tool (SADAPT-TRAN) for nonlinear mixed-effects modeling in S-ADAPT","volume":"13","author":"Bulitta","year":"2011","journal-title":"AAPS J"},{"key":"10.1016\/j.xphs.2025.103843_bib0019","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejps.2018.05.017","article-title":"Comparison of dissolution time profiles: No similarity but where is the difference?","volume":"121","author":"Horkovics-Kovats","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.103843_bib0020","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ejps.2017.10.018","article-title":"Physicochemical pharmacokinetics as an optimization tool for generic development: a case study","volume":"111","author":"Horkovics-Kovats","year":"2018","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2025.103843_bib0021","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1208\/s12248-011-9258-9","article-title":"Performance and robustness of the Monte Carlo importance sampling algorithm using parallelized S-ADAPT for basic and complex mechanistic models","volume":"13","author":"Bulitta","year":"2011","journal-title":"AAPS J"},{"key":"10.1016\/j.xphs.2025.103843_bib0022","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-006-0162-4","article-title":"Oral absorption of poorly water-soluble drugs: Computer simulation of fraction absorbed in humans from a miniscale dissolution test","author":"Takano","year":"2006","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2025.103843_bib0023","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejps.2016.05.003","article-title":"Dissolution and coarsening of polydisperse, polymorph drug particles liberated from a disintegrating finished dosage form: Theoretical considerations","volume":"91","author":"Horkovics-Kovats","year":"2016","journal-title":"Eur J Pharm Sci"},{"issue":"12","key":"10.1016\/j.xphs.2025.103843_bib0024","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3390\/pharmaceutics16121587","article-title":"The development of an age-appropriate fixed dose combination for tuberculosis using Physiologically-Based Pharmacokinetic Modeling (PBBM) and risk assessment","volume":"16","author":"Pepin","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2025.103843_bib0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejpb.2022.09.007","article-title":"Direct visualizing of paracetamol immediate release tablet disintegration in vivo and in vitro","volume":"180","author":"Fredholt","year":"2022","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2025.103843_bib0026","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jddst.2019.02.027","article-title":"In-vivo disintegration and absorption of two fast acting aspirin tablet formulations compared to ibuprofen tablets using pharmacoscintigraphy","volume":"51","author":"Stevens","year":"2019","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.xphs.2025.103843_bib0027","doi-asserted-by":"crossref","DOI":"10.1002\/jps.22778","article-title":"Comparison of methods for predicting dissolution and the theoretical implications of particle-size-dependent solubility","author":"Johnson","year":"2012","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.103843_bib0028","article-title":"Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs","author":"Junyaprasert","year":"2015","journal-title":"Asian J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2025.103843_bib0029","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/0192623307310946","article-title":"Drug nanoparticles: formulating poorly water-soluble compounds","volume":"36","author":"Merisko-Liversidge","year":"2008","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.xphs.2025.103843_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2005.11.013","article-title":"Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs","author":"Jinno","year":"2006","journal-title":"J Controll Rel"},{"key":"10.1016\/j.xphs.2025.103843_bib0031","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"issue":"15-16","key":"10.1016\/j.xphs.2025.103843_bib0032","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s10337-014-2648-2","article-title":"Identification of in vitro metabolites of amoxicillin in human liver microsomes by LC-ESI\/MS","volume":"77","author":"Szultka","year":"2014","journal-title":"Chromatographia"},{"issue":"2","key":"10.1016\/j.xphs.2025.103843_bib0033","first-page":"69","article-title":"Amoxicillin levels in human serum, lung and liver tissues, gallbladder and bile","volume":"19","author":"Kiss","year":"1981","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1016\/j.xphs.2025.103843_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2018.03.002","article-title":"Interindividual and intraindividual variability of fasted state gastric fluid volume and gastric emptying of water","volume":"127","author":"Grimm","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"10.1016\/j.xphs.2025.103843_bib0035","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1128\/AAC.17.2.199","article-title":"Absorption and disposition kinetics of amoxicillin in normal human subjects","volume":"17","author":"Arancibia","year":"1980","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.xphs.2025.103843_bib0036","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jconrel.2015.10.022","article-title":"Intragastric pH and pressure profiles after intake of the high-caloric, high-fat meal as used for food effect studies","volume":"220","author":"Koziolek","year":"2015","journal-title":"J Controll Rel"},{"issue":"5","key":"10.1016\/j.xphs.2025.103843_bib0037","doi-asserted-by":"crossref","DOI":"10.1021\/mp300604u","article-title":"Simulating the postprandial stomach: Physiological considerations for dissolution and release testing","volume":"10","author":"Koziolek","year":"2013","journal-title":"Mol Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2025.103843_bib0038","first-page":"173","article-title":"Practical gastric physiology","volume":"9","author":"Jolliffe","year":"2009","journal-title":"Cont Educ Anaesthesia Crit Care Pain"},{"issue":"10","key":"10.1016\/j.xphs.2025.103843_bib0039","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1365-2036.2005.02683.x","article-title":"Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging","volume":"22","author":"Schiller","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.xphs.2025.103843_bib0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1208\/s12248-019-0297-y","article-title":"First-principles and empirical approaches to predicting in vitro dissolution for pharmaceutical formulation and process development and for product release testing","volume":"21","author":"Zaborenko","year":"2019","journal-title":"AAPS J"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925002965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925002965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T18:13:33Z","timestamp":1756404813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354925002965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0022354925002965"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103843","relation":{},"ISSN":["0022-3549"],"issn-type":[{"type":"print","value":"0022-3549"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disintegration-dissolution modeling of bilayer tablets: Predicting plasma profiles and antimicrobial efficacy under postprandial conditions","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103843","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of American Pharmacists Association.","name":"copyright","label":"Copyright"}],"article-number":"103843"}}